IP Verse

Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody

Patent No. EP2206728 (titled "Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody") was filed by Regents OF The University OF Minnesota on Apr 7, 2005. The application was issued on Oct 10, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSDec 14, 2018MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2206728

REGENTS OF THE UNIVERSITY OF MINNESOTA
Application Number
EP10151672A
Filing Date
Apr 7, 2005
Status
Revoked
Nov 4, 2022
Publication Date
Oct 10, 2018
External Links
Slate, Register , Google Patents